TGN-1412

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTGN-1412
Drug Alias NameAnti-CD28 monoclonal antibody - TeGeneroTGN-1412
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunostimulantsT-cell-specific surface glycoprotein CD28 agonists
TargetsT-cell-specific surface glycoprotein CD28
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTegenero
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTegenero
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A